ReviewFrontiers in immunology2023

Changes in the molecular profiles of large-vessel vasculitis treated with biological disease-modifying anti-rheumatic drugs and Janus kinase inhibitors.

Kotaro Matsumoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.